â‚©
7560.00
Oct 18
Business Description
SeouLinBioscience Co Ltd
ISIN : KR7038070009
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 11.44 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 5.68 | |||||
Interest Coverage | 0.96 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.43 | |||||
Beneish M-Score | -2.37 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.2 | |||||
3-Year EBITDA Growth Rate | -38.2 | |||||
3-Year EPS without NRI Growth Rate | -38.8 | |||||
3-Year Book Growth Rate | 10.2 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 67.98 | |||||
9-Day RSI | 53.66 | |||||
14-Day RSI | 47.5 | |||||
6-1 Month Momentum % | -12.18 | |||||
12-1 Month Momentum % | -9.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.92 | |||||
Quick Ratio | 2.51 | |||||
Cash Ratio | 1.76 | |||||
Days Inventory | 129.67 | |||||
Days Sales Outstanding | 39.55 | |||||
Days Payable | 51.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.33 | |||||
Dividend Payout Ratio | 0.61 | |||||
Forward Dividend Yield % | 1.33 | |||||
5-Year Yield-on-Cost % | 1.33 | |||||
3-Year Average Share Buyback Ratio | -1.2 | |||||
Shareholder Yield % | 17.38 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 22.14 | |||||
Operating Margin % | 1.66 | |||||
Net Margin % | -0.7 | |||||
FCF Margin % | 5.05 | |||||
ROE % | -0.7 | |||||
ROA % | -0.5 | |||||
ROIC % | 2.39 | |||||
ROC (Joel Greenblatt) % | -3.05 | |||||
ROCE % | -1.1 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 46.18 | |||||
PS Ratio | 0.75 | |||||
PB Ratio | 0.78 | |||||
Price-to-Tangible-Book | 0.78 | |||||
Price-to-Free-Cash-Flow | 14.41 | |||||
Price-to-Operating-Cash-Flow | 13.18 | |||||
EV-to-EBIT | -40.61 | |||||
EV-to-EBITDA | 90.86 | |||||
EV-to-Revenue | 0.46 | |||||
EV-to-FCF | 8.65 | |||||
Price-to-Projected-FCF | 0.68 | |||||
Price-to-Median-PS-Value | 0.47 | |||||
Price-to-Graham-Number | 1.27 | |||||
Price-to-Net-Current-Asset-Value | 1.49 | |||||
Price-to-Net-Cash | 7.36 | |||||
Earnings Yield (Greenblatt) % | -2.46 | |||||
FCF Yield % | 6.59 | |||||
Forward Rate of Return (Yacktman) % | 3.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
SeouLinBioscience Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 84,514.061 | ||
EPS (TTM) (â‚©) | -69.791 | ||
Beta | 1.28 | ||
Volatility % | 25.39 | ||
14-Day RSI | 47.5 | ||
14-Day ATR (â‚©) | 246.116346 | ||
20-Day SMA (â‚©) | 7554 | ||
12-1 Month Momentum % | -9.67 | ||
52-Week Range (â‚©) | 6820 - 12240 | ||
Shares Outstanding (Mil) | 8.55 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SeouLinBioscience Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SeouLinBioscience Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
SeouLinBioscience Co Ltd Frequently Asked Questions
What is SeouLinBioscience Co Ltd(XKRX:038070)'s stock price today?
When is next earnings date of SeouLinBioscience Co Ltd(XKRX:038070)?
Does SeouLinBioscience Co Ltd(XKRX:038070) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |